BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30345496)

  • 41. Effects on renal function of obstructive and nonobstructive dilatation of the upper urinary tract in ileal neobladders with refluxing ureteroenteric anastomoses.
    Minervini R; Pagni R; Mariani C; Morelli A; Morelli G; Minervini A
    Eur J Surg Oncol; 2010 Mar; 36(3):287-91. PubMed ID: 19796914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
    JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy.
    Nielsen N; Wrist Lam G; Fabrin K; Holt P; Thind PO; Jensen JB
    Scand J Urol; 2019 Aug; 53(4):213-216. PubMed ID: 31174449
    [No Abstract]   [Full Text] [Related]  

  • 45. Short- and Long-Term Evaluation of Renal Function after Radical Cystectomy and Cutaneous Ureterostomy in High-Risk Patients.
    Creta M; Fusco F; La Rocca R; Capece M; Celentano G; Imbimbo C; Imperatore V; Russo L; Mangiapia F; Mirone V; Russo D; Longo N
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32664517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.
    Gamal El-Deen HS
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):133-46. PubMed ID: 19034344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
    Yao Z; Jiang Y; Zhu X; Wu B; Bai S
    Int J Clin Oncol; 2020 Jul; 25(7):1377-1384. PubMed ID: 32318904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
    Huguet J; Gaya JM; Sabaté S; Palou J; Villavicencio H
    Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder Cancer.
    Miyake M; Owari T; Tomizawa M; Matsui M; Nishibayashi N; Iida K; Onishi K; Hori S; Morizawa Y; Gotoh D; Itami Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
    Urol J; 2019 May; 16(2):145-151. PubMed ID: 30955203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
    Gakis G; Efstathiou J; Lerner SP; Cookson MS; Keegan KA; Guru KA; Shipley WU; Heidenreich A; Schoenberg MP; Sagaloswky AI; Soloway MS; Stenzl A;
    Eur Urol; 2013 Jan; 63(1):45-57. PubMed ID: 22917985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
    Aziz A; Gierth M; Fritsche HM; May M; Otto W; Denzinger S; Wieland WF; Merseburger A; Riedmiller H; Kocot A; Burger M
    Urol Int; 2013; 91(1):97-102. PubMed ID: 23751372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion.
    Gondo T; Ohno Y; Nakashima J; Hashimoto T; Nakagami Y; Tachibana M
    Int Urol Nephrol; 2017 Feb; 49(2):233-238. PubMed ID: 27873153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radical cystectomy versus alternative treatments for muscle-confined bladder cancer.
    Tekin A; Aki FT; Ozen H
    Int Urol Nephrol; 2001; 33(2):357-62. PubMed ID: 12092656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term renal function outcomes in bladder cancer after radical cystectomy.
    Osawa T; Shinohara N; Maruyama S; Oba K; Abe T; Maru S; Takada N; Sazawa A; Nonomura K
    Urol J; 2013; 10(1):784-9. PubMed ID: 23504683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy.
    Robins D; Matulay J; Lipsky M; Meyer A; Ghandour R; DeCastro G; Anderson C; Drake C; Benson M; McKiernan JM
    Urology; 2018 Jan; 111():116-121. PubMed ID: 29032239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.
    Orré M; Latorzeff I; Fléchon A; Roubaud G; Brouste V; Gaston R; Piéchaud T; Richaud P; Chapet O; Sargos P
    PLoS One; 2017; 12(4):e0174978. PubMed ID: 28384195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience.
    Shah SH; Movassaghi K; Skinner D; Dalag L; Miranda G; Cai J; Schuckman A; Daneshmand S; Djaladat H
    Urology; 2015 Jul; 86(1):87-91. PubMed ID: 25987494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.